Showing 1–12 of 42 results
-
Avaxim (Hepatitis A) PFS – 0.5ml (1) *POM*
£65.75 + VATAVAXIM is indicated for active immunisation against infection caused by hepatitis A virus in susceptible adults and adolescents of 16 years of age and above. -
Avaxim (Hepatitis A) PFS – 0.5ml (10) *POM*
£657.24 + VATAVAXIM is indicated for active immunisation against infection caused by hepatitis A virus in susceptible adults and adolescents of 16 years of age and above. -
-
Dukoral – Oral Cholera Vaccine (2 Vial & 2 Sachets) *POM*
£72.59 + VATDUKORAL is indicated for active immunisation against disease caused by Vibrio cholerae serogroup O1 in adults and children from 2 years of age who will be visiting endemic/epidemic areas. -
Dukoral – Oral Cholera Vaccine (2 Vial & 2 Sachets) *POM*
£72.59 + VATDUKORAL is indicated for active immunisation against disease caused by Vibrio cholerae serogroup O1 in adults and children from 2 years of age who will be visiting endemic/epidemic areas. -
Engerix B PFS (Hepatitis B) – 20mcg/1ml (1) *POM*
£44.07 + VATEngerix B is indicated for active immunisation against hepatitis B virus infection (HBV) caused by all known subtypes in non immune subjects.It can be expected that hepatitis D will also be prevented by immunisation with Engerix B as hepatitis D... -
Engerix B PFS (Hepatitis B) – 20mcg/1ml (10) *POM*
£405.43 + VATEngerix B is indicated for active immunisation against hepatitis B virus infection (HBV) caused by all known subtypes in non immune subjects.It can be expected that hepatitis D will also be prevented by immunisation with Engerix B as hepatitis D... -
Engerix B Vial (Hepatitis B) – 20mcg/1ml (1) *POM*
£42.39 + VATEngerix B is indicated for active immunisation against hepatitis B virus infection (HBV) caused by all known subtypes in non immune subjects. The 20 µg dose vaccine in 1.0 ml suspension is intended for use in subjects 16 years of age and above. -
-
Engerix B Vial (Hepatitis B) – 20mcg/1ml (10) *POM*
£405.43 + VATEngerix B is indicated for active immunisation against hepatitis B virus infection (HBV) caused by all known subtypes in non immune subjects. The 20 µg dose vaccine in 1.0 ml suspension is intended for use in subjects 16 years of age and above. -
-
Havrix Monodose (Hepatitis A) PFS – 1ml (1) *POM*
£75.97 + VATActive immunisation against infections caused by hepatitis A virus. The vaccine is particularly indicated for those at increased risk of infection or transmission.